Bromide

Bromide

SCHEMBL2347780

Br.CCCCCN1CCOCC1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 3/20 0.58
CHRM2 known ✓ P08172 1/20 0.58
ALDH1A1 P00352 4/20 0.58
MAPK1 P28482 2/20 0.58
CYP1A2 P05177 1/20 0.58
CHRM1 P11229 1/20 0.58
HTR2A P28223 1/20 0.58
SCN1A P35498 1/20 0.58
HTR2B P41595 1/20 0.58
KCNH2 Q12809 1/20 0.58
SCN2A Q99250 1/20 0.58
SCN3A Q9NY46 1/20 0.58
HRH3 Q9Y5N1 1/20 0.58
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
KEAP1 Q14145 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
GNAI3 P08754 3/20 0.50
GNAO1 P09471 3/20 0.50
GNAI1 P63096 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL10982102 0.98 MAPK1 (0.56) ALDH1A1SIGMAR1MAPK1CYP1A2CHRM2
SCHEMBL5251269 0.98 ALDH1A1 (0.59) ALDH1A1SIGMAR1MAPK1CYP1A2CHRM2
SCHEMBL40487 0.98 ALDH1A1 (0.59) ALDH1A1SIGMAR1MAPK1CYP1A2CHRM2
Bromide SCHEMBL27876655 0.96 MAPK1 (0.54) ALDH1A1SIGMAR1MAPK1CYP1A2CHRM2
Bromide SCHEMBL27860070 0.96 MAPK1 (0.54) ALDH1A1SIGMAR1MAPK1CYP1A2CHRM2
Bromide SCHEMBL28503801 0.96 MAPK1 (0.54) ALDH1A1SIGMAR1MAPK1CYP1A2CHRM2
SCHEMBL10721706 0.95 MAPK1 (0.58) ALDH1A1SIGMAR1MAPK1CYP1A2CHRM2
SCHEMBL1262440 0.95 MAPK1 (0.58) ALDH1A1SIGMAR1MAPK1CYP1A2CHRM2
SCHEMBL11479545 0.95 MAPK1 (0.58) ALDH1A1SIGMAR1MAPK1CYP1A2CHRM2
SCHEMBL351640 0.95 MAPK1 (0.58) ALDH1A1SIGMAR1MAPK1CYP1A2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1698631-B1 IONIC LIQUID, METHOD FOR PRODUCING SAME, DOUBLE LAYER CAPACITOR COMPRISING SAME, AND LITHIUM BATTERY NAT INST OF ADVANCED IND SCIEN (JP) 2011-08-10 EP disclosed
US-20070099079-A1 Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2007-05-03 US disclosed
EP-1698631-A1 IONIC LIQUID, METHOD FOR PRODUCING SAME, DOUBLE LAYER CAPACITOR COMPRISING SAME, AND LITHIUM BATTERY National Institute of Advanced Industrial Science and Technology (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099079-A1 Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery CLCN2, CACNA1F, CACNB3 SIGMAR1 4039/4885CHRM2 909/4885ALDH1A1 3860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.